LLY - Eli Lilly & Co.

Day 1m 10m 60m PreMarket Market AfterHours Gap
813.0 13.05 (1.61%) --- 0.0 (0.0%) 0.0 (0.0%) 0.0 (0.0%) 14.29 (1.76%) -0.52 (-0.06%) -0.52 (-0.06%)

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
6.3
Diluted EPS:
6.29
Basic P/E:
131.1195
Diluted P/E:
131.3279
RSI(14) 1m:
0.0
VWAP:
826.05
RVol:
0.4779

Events

Period Kind Movement Occurred At

Related News